The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) have recognized the lower risk profile of marijuana compared to other Schedule I drugs like heroin, supporting its reclassification as a Schedule III substance. This move, aimed at rescheduling marijuana, is intended to strengthen standards, eliminate illegal markets, and promote research into cannabis use's effects, especially on youth. The Drug Enforcement Administration (DEA) also supports the reclassification, which could significantly impact how medical practitioners operate and is viewed as a major step toward ending marijuana prohibition nationwide.
HHS may blaze a new trail by recommending loosened marijuana restrictions The HHS review concluded marijuana was less likely to cause negative outcomes compared to other Schedule I drugs like heroin. $MSOS $MSOX $YOLO https://t.co/mAUx2VCmjZ https://t.co/m6rxh4lYMT
Rescheduling could change how medical practitioners do business: Q&A with marijuana health pros $MSOS $MSOX $YOLO https://t.co/Usgo6y5riX via @MJBizDaily
Marijuana's current federal schedule is irrational and has caused immense harm. The FDA finally admitting cannabis doesn't belong on Schedule I with heroin is a huge step toward ending prohibition. It's long past time to legalize marijuana nationwide. https://t.co/qupBSSGhu9
There are several good reasons for the DEA to reschedule legal cannabis in the interest of public health and safety. The move, supported by FDA, aims to strengthen standards, eliminate illegal markets, and promote research into the effects of cannabis use, particularly on youth.… https://t.co/BhrQhpUxVZ
Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions researchers from the US Food and Drug Administration say in documents supporting its reclassification as a Schedule III substance. https://t.co/L9DZvcENza
The Newly Unveiled HHS Rationale for Rescheduling Marijuana Underlines Drug Warriors' Dishonesty The points about marijuana's risks and benefits that the department now concedes were clear long before last August. $MSOS $MSOX $YOLO https://t.co/U9uiZG52Oh via @reason